polynucleotide


Also found in: Dictionary, Medical, Wikipedia.
Related to polynucleotide: Polynucleotide Kinase, Polynucleotide phosphorylase

polynucleotide

[¦päl·ə′nü·klē·ə‚tīd]
(biochemistry)
A linear sequence of nucleotides.
References in periodicals archive ?
8,313,910 "Isolated Genomic Polynucleotide Fragments from Chromosome 12 that Encode Human Mouse Double Minute 2 Homolog" teaches a method of isolation of specific parts of genomic sequence, which encodes a protein, regulating the tumor suppressor gene p53, the so called "guardian of genome;" it can act as an alternative to cytotoxic chemotherapy in many tumor cells.
7,786,280, titled "Isolated genomic polynucleotide fragments from chromosome 10q25.
Patent and Trademark Office, claims isolated genomic polynucleotide fragments that encode human adipocyte enhancer binding protein 1 (AEBP1), complementary polynucleotides, vectors and host cells containing these fragments and a method for obtaining AEBP1.
The goal of the complete project is to produce a safe, effective, easy-to-use, polynucleotide vaccine delivery system that can be used against biodefense pathogens.
The '765 Patent covers the structure of the PCA3 gene, its polynucleotide sequences and various methods for detecting the nucleic acids.
7,468,266 titled "Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2" and 7,470,522 , titled "Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2" cover isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, human resistin and human syntaxin binding protein 2, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments and methods of using these fragments to obtain the coded proteins and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided.
EXETER, England, November 10 /PRNewswire/ -- Mobious Genomics Ltd, the UK based bionanotechnology company is pleased to announce that it has received formal notice of grant from the United States Patent Office for a broad technology defining patent (US 6908736) covering real-time polynucleotide sequencing.
This innovative technology is used to discover and produce therapeutics such as monoclonal antibodies and polynucleotide vaccines and to deliver DNA and RNA vaccines.
Organon (Oss, Netherlands) has patented a protein having an amino acid sequence as in SEQ ID 7, 8, 11 or 12, similar proteins, naturally occurring variants and homologous functional equivalents thereof, as well as the use of a polynucleotide encoding such protein, for use in an assay and for use in a method of modulation of transcriptional activity promoted by a responsive nuclear receptor and a coactivator, which coactivator is the mentioned protein and is named COASTER, and which nuclear receptor is preferrably a steroid receptor.
Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen.
The patent describes a global whole genome amplification methodology using composite DNA/RNA primers able to anneal to multiple sites within the template polynucleotide.